MedTrace Logo

Pharmacogenomics Registry to Assess Clinical Utility

NCT02374840 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 340778

Last updated 2015-07-22

No results posted yet for this study

Summary

The PREACT Registry aims to see whether data from Pharmacogenomic Testing (PGx) can help healthcare providers manage patient medication regimens and assess if the testing has an effect on reducing medication side effects, hospitalizations and emergency department visits.

The way an individual processes a drug is in part determined by their genes, and there is known to be genetic variation between humans in the way drugs are metabolized. The study of the way genes affect a person's response to drugs is known as "Pharmacogenomics."

Conditions

  • Drug Side Effects

Sponsors & Collaborators

  • Companion Dx Reference Lab, LLC

    lead INDUSTRY

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2019-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02374840 on ClinicalTrials.gov